Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis

P. H. Hofschneider;  ; U. Winter; E. -M. Lemmel; B. Brölz; W. Gaus; S. Schmid; H. -J. Obert; C. Stetter; I. O. Auer; C. Papst; W. H. Boesken; H. E. Stierle; U. Botzenhardt; W. Reemtsen; D. Brackertz; D. Richter; V. Diehl; A. K. von Kalle; C. Gärtner; S. Herzig; J. Goronzy; C. Weyand; J. R. Kalden; F. Strobel; K. Machalke; H. H. Peter; S. Meske; M. Schattenkirchner; K. Krüger; R. Sprekeler; H. D. Waller; J. G. Saal; H. Warnatz; G. Lemm; K. Wilms; T. Stolzenburg

doi:10.1007/bf00302149

Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis

Rheumatology International ◽

10.1007/bf00302149 ◽

1992 ◽

Vol 12 (5) ◽

pp. 175-185 ◽

Cited By ~ 24

Author(s):

P. H. Hofschneider ◽

◽

U. Winter ◽

E. -M. Lemmel ◽

B. Brölz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Interferon Gamma ◽

Phase Iii ◽

Multicenter Clinical Trial ◽

Double Blind

Download Full-text

A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis

Arthritis Research & Therapy ◽

10.1186/s13075-017-1371-4 ◽

2017 ◽

Vol 19 (1) ◽

Cited By ~ 10

Author(s):

Ahmadreza Jamshidi ◽

Farhad Gharibdoost ◽

Mahdi Vojdanian ◽

Soosan G. Soroosh ◽

Mohsen Soroush ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Active Rheumatoid Arthritis ◽

Reference Product ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.01.013 ◽

2017 ◽

Vol 23 (3) ◽

pp. S24-S25 ◽

Cited By ~ 3

Author(s):

Drew J. Winston ◽

Kathleen M. Mullane ◽

Michael J. Boeckh ◽

Oliver A. Cornely ◽

Kimberly Hurtado ◽

...

Keyword(s):

Clinical Trial ◽

Hematopoietic Cell ◽

Phase Iii ◽

Multicenter Clinical Trial ◽

Double Blind ◽

Cell Transplants

Download Full-text

A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate

Rheumatology International ◽

10.1007/s00296-014-2989-z ◽

2014 ◽

Vol 34 (11) ◽

pp. 1519-1527

Author(s):

Wei Fan ◽

Dong-bao Zhao ◽

Shao-Xian Hu ◽

Hu-ji Xu ◽

Xiao Zhang ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Fusion Protein ◽

T Lymphocyte ◽

Active Rheumatoid Arthritis ◽

Cytotoxic T Lymphocyte ◽

Inadequate Response ◽

Multicenter Clinical Trial ◽

Double Blind ◽

Lymphocyte Antigen

Download Full-text

A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis

Arthritis Research & Therapy ◽

10.1186/ar2870 ◽

2009 ◽

Vol 11 (6) ◽

pp. R180 ◽

Cited By ~ 24

Author(s):

Wei Wei ◽

Ling-Ling Zhang ◽

Jian-Hua Xu ◽

Feng Xiao ◽

Chun-De Bao ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Type Ii Collagen ◽

Phase Iii ◽

Type Ii ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Randomized Controlled

Download Full-text

Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.05.006 ◽

2007 ◽

Vol 29 (5) ◽

pp. 862-873 ◽

Cited By ~ 23

Author(s):

Yeong Wook Song ◽

Eun Young Lee ◽

Eun-Mi Koh ◽

Hoon-Suk Cha ◽

Bin Yoo ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Pain Relief ◽

Phase Iii ◽

Double Blind

Download Full-text

Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma

Rheumatology International ◽

10.1007/bf00271840 ◽

1988 ◽

Vol 8 (2) ◽

pp. 87-93 ◽

Cited By ~ 61

Author(s):

E. M. Lemmel ◽

D. Brackertz ◽

M. Franke ◽

W. Gaus ◽

P. W. Hartl ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Study ◽

Interferon Gamma ◽

Phase Iii ◽

Double Blind ◽

Recombinant Interferon

Download Full-text

Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial

BMC Musculoskeletal Disorders ◽

10.1186/1471-2474-15-375 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 5

Author(s):

In Ah Choi ◽

Han-Joo Baek ◽

Chul-Soo Cho ◽

Yeon-Ah Lee ◽

Won Tae Chung ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

Faculty Opinions recommendation of Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119107.577195 ◽

2008 ◽

Author(s):

Stewart Factor

Keyword(s):

Parkinson’S Disease ◽

Clinical Trial ◽

Receptor Antagonist ◽

Adenosine A2a Receptor ◽

Multicenter Clinical Trial ◽

Double Blind ◽

A2a Receptor ◽

Adenosine A2a Receptor Antagonist ◽

Adenosine A2a ◽

Off Time

Download Full-text

Faculty Opinions recommendation of Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1229980.697084 ◽

2009 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text